Delivery Order SPE2DB24D2010-SPE2DB25FAAQT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $10,745.91. This firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $6,657.98. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Jardiance 10mg tablets in a 90-count configuration, with a ceiling value of $37,525.90. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a non-set-aside competitive award to the prime contractor. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,277.15 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 18, 2025, with a completion date of July 21, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and leverages AmerisourceBergen's existing contract infrastructure to supply pharmaceutical products to federal military and healthcare systems. The award is performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Jardiance 10 mg tablets (90-count) valued at $14,902.44 under a firm fixed price contract. This is a non-set-aside delivery order with an ultimate completion date of August 19, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $7,330.39. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by May 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $7,039.81. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by July 30, 2025. The contract fulfillment will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,457.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order represents a single...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAQTDelivery Order
The Defense Logistics Agency awarded a $7,563.77 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Jardiance 10 mg tablets (90-count package). This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications for diabetes management, neurological treatments, pain management, antibiotics, and specialized medical supplies. This award demonstrates AmerisourceBergen's continued capability to fulfill federal medical procurement requirements through the DLA's pharmaceutical supply chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/4/25 |